發送短信 : Switching to Fixed-Dose Bictegravir, Emtricitabine, and Tenofovir Alafenamide (B/F/TAF) in Virologically Suppressed HIV-1 Infected Women: A Randomized, Open-Label, Multicenter, Active-Controlled, Phase 3, Noninferiority Trial

  ____     __   __   __   _     _____     ______  
 |  _ \\   \ \\/ // | || | ||  |  ___||  /_   _// 
 | |_| ||   \ ` //  | '--' ||  | ||__      | ||   
 | .  //     | ||   | .--. ||  | ||__     _| ||   
 |_|\_\\     |_||   |_|| |_||  |_____||  /__//    
 `-` --`     `-`'   `-`  `-`   `-----`   `--`